Webinar: Treatment strategies for actinic keratosis

In this webinar in collaboration with La Roche-Posay, Skin Cancer Doctor John O'Bryen explores pre- and post-treatment strategies for actinic keratosis.

Author
HealthCert Education

1 minute read September 18, 2024

Optimising care: Pre- and post-treatment strategies for actinic keratosis in your skin cancer practice.

In this webinar delivered in collaboration with La Roche-Posay, Skin Cancer Doctor John O'Bryen delves into the critical aspects of pre- and post-care treatment guidelines for actinic keratosis and provides invaluable insights for GPs with an interest in skin.

Australia has the highest incidence of actinic keratosis in the world. In the state of Queensland alone, up to 60 per cent of people aged over 40 have actinic keratosis.

In the full webinar recording below, Dr John O’Bryen explores evidence-based strategies for optimising patient outcomes from initial assessment to treatment selection, including post-treatment care protocols to ensure effective healing and minimised risk of recurrence.

Watch the webinar to navigate new guidelines and be empowered with the knowledge and tools to manage actinic keratosis in your clinical practice.

Watch the full recording here:

Click here to download the full slide deck.

Skin cancer doctor Dr John O’Bryen is a specialist GP who regularly performs skin cancer checks and is trained in the surgical and non-surgical management of skin cancers, including the use of skin flaps and grafts when required. He works closely with local surgeons, dermatologists and radiation oncologists. Outside of the consult room, he teaches medical students, volunteers as a helpline panellist for Doctors Health Queensland, and has featured as a guest speaker at charity events. Dr O’Bryen has numerous publications and is a peer reviewer for the Australian Journal of General Practice.